Charge affects the oral toxicity of poly(amidoamine) dendrimers

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 84, Issue 2, 2013, Pages 330-334

  Thiagarajan, Giridhar ^a,b   Greish, Khaled ^b,c   Ghandehari, Hamidreza ^a,b  

^a University of Utah   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Acute toxicity; Drug delivery; In vivo; Oral drug carriers; PAMAM dendrimers; Surface charge

Indexed keywords

DENDRIMER; POLYAMIDOAMINE;

ACUTE TOXICITY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BILIARY TRACT HEMORRHAGE; DRUG DELIVERY SYSTEM; FEMALE; MAXIMUM TOLERATED DOSE; MOLECULAR WEIGHT; MOUSE; MOUTH TOXICITY; NONHUMAN; SPLENOMEGALY; TOXICITY;

ADMINISTRATION, ORAL; ANIMALS; CATIONS; DENDRIMERS; DRUG CARRIERS; FEMALE; HEMOBILIA; INTESTINES; MAXIMUM TOLERATED DOSE; MICE; POLYAMINES; SPLENOMEGALY; SURFACE PROPERTIES;

EID: 84878289500     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2013.01.019     Document Type: Article

References (23)

1. G. Thiagarajan, and H. Ghandehari Dendrimers for drug delivery J.D. Bronzino, D.R. Peterson, The Biomedical Engineering Handbook 2012 CRC Press
2. S. Svenson, and D.A. Tomalia Dendrimers in biomedical applications - reflections on the field Adv. Drug Deliv. Rev. 57 2005 2106 2129
3. H.L. Crampton, and E.E. Simanek Dendrimers as drug delivery vehicles: non-covalent interactions of bioactive compounds with dendrimers Polym. Int. 56 2007 489 496
4. M. El-Sayed, M. Ginski, C. Rhodes, and H. Ghandehari Transepithelial transport of poly(amidoamine) dendrimers across Caco-2 cell monolayers J. Control. Release 81 2002 355 365
5. K.M. Kitchens, R.B. Kolhatkar, P.W. Swaan, N.D. Eddington, and H. Ghandehari Transport of poly(amidoamine) dendrimers across Caco-2 cell monolayers: Influence of size, charge and fluorescent labeling Pharm. Res. 23 2006 2818 2826
6. R.B. Kolhatkar, P. Swaan, and H. Ghandehari Potential oral delivery of 7-ethyl-10-hydroxy-camptothecin (SN-38) using poly(amidoamine) dendrimers Pharm. Res. 25 2008 1723 1729
7. R. Wiwattanapatapee, B. Carreno-Gomez, N. Malik, and R. Duncan Anionic PAMAM dendrimers rapidly cross adult rat intestine in vitro: a potential oral delivery system? Pharm. Res. 17 2000 991 998
8. M. Najlah, S. Freeman, D. Attwood, and A. D'Emanuele In vitro evaluation of dendrimer prodrugs for oral drug delivery Int. J. Pharm. 336 2007 183 190
9. N. Vijayalakshmi, A. Ray, A. Malugin, and H. Ghandehari Carboxyl-terminated PAMAM-SN38 conjugates: synthesis, characterization, and in vitro evaluation Bioconjug. Chem. 21 2010 1804 1810
10. R.B. Kolhatkar, K.M. Kitchens, P.W. Swaan, and H. Ghandehari Surface acetylation of polyamidoamine (PAMAM) dendrimers decreases cytotoxicity while maintaining membrane permeability Bioconjug. Chem. 18 2007 2054 2060
11. S. Sadekar, and H. Ghandehari Transepithelial transport and toxicity of PAMAM dendrimers: implications for oral drug delivery Adv. Drug Deliv. Rev. 64 2012 571 588
12. K. Greish, G. Thiagarajan, H. Herd, P. Price, H. Bauer, D. Hubbard, A. Burckle, S. Sadekar, T. Yu, A. Anwar, A. Ray, and H. Ghandehari Size and surface charge significantly influence the toxicity of silica and dendritic nanoparticles Nanotoxicology 6 2011 718 728
13. P. Jani, G.W. Halbert, J. Langridge, and A.T. Florence Nanoparticle uptake by the rat gastrointestinal mucosa: quantitation and particle size dependency J. Pharm. Pharmacol. 42 1990 821 826
14. B.S. Wilkins, and D.H. Wright Illustrated Pathology of the Spleen 2000 Cambridge University Press Cambridge, UK
15. M.H.A. Green, R.M. Duell, C.D. Johnson, and N.V. Jamieson Haemobilia Br. J. Surg. 88 2001 773 786
16. P. Baldrick The safety of chitosan as a pharmaceutical excipient Regul. Toxicol. Pharmacol. 56 2010 290 299
17. G. Thiagarajan, S. Sadekar, K. Greish, A. Ray, H. Ghandehari, Evidence of oral translocation of anionic G6.5 dendrimers in mice, Mol. Pharm., 2013 Jan 25. [Epub ahead of print].
18. M. Zondlo Fiume Final report on the safety assessment of acrylates copolymer and 33 related cosmetic ingredients Int. J. Toxicol. 21 Suppl. 3 2002 1 50
19. R. Jevprasesphant, J. Penny, R. Jalal, D. Attwood, N.B. McKeown, and A. D'Emanuele The influence of surface modification on the cytotoxicity of PAMAM dendrimers Int. J. Pharm. 252 2003 263 266
20. D.S. Goldberg, H. Ghandehari, and P.W. Swaan Cellular entry of G3.5 poly (amido amine) dendrimers by clathrin- and dynamin-dependent endocytosis promotes tight junctional opening in intestinal epithelia Pharm. Res. 2010
21. K.M. Kitchens, A.B. Foraker, R.B. Kolhatkar, P.W. Swaan, and H. Ghandehari Endocytosis and interaction of poly (amidoamine) dendrimers with Caco-2 cells Pharm. Res. 24 2007 2138 2145
22. K.M. Kitchens, R.B. Kolhatkar, P.W. Swaan, and H. Ghandehari Endocytosis inhibitors prevent poly(amidoamine) dendrimer internalization and permeability across Caco-2 cells Mol. Pharm. 5 2008 364 369
23. D.S. Goldberg, N. Vijayalakshmi, P.W. Swaan, and H. Ghandehari G3.5 PAMAM dendrimers enhance transepithelial transport of SN38 while minimizing gastrointestinal toxicity J. Control. Release 150 2011 318 325